Exploiting a host-commensal interaction to promote intestinal barrier function and enteric pathogen tolerance

Science Immunology

Volumn 1, Issue 3, 2016, Pages

  Pedicord, Virginia A ^a   Lockhart, Ainsley A K ^a   Rangan, Kavita J ^a   Craig, Jeffrey W ^b   Loschko, Jakob ^a   Rogoz, Aneta ^a   Hang, Howard C ^a   Mucida, Daniel ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85029290847     PISSN: None     EISSN: 24709468     Source Type: Journal    
DOI: 10.1126/sciimmunol.aai7732     Document Type: Article

References (73)

1. R. Sender, S. Fuchs, R. Milo, Revised estimates for the number of human and bacteria cells in the body. PLOS Biol. 14, e1002533 (2016).
2. M. F. Gregor, G. S. Hotamisligil, Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415–445 (2011).
3. D. A. Winer, H. Luck, S. Tsai, S. Winer, The intestinal immune system in obesity and insulin resistance. Cell Metab. 23, 413–426 (2016).
4. J. C. Clemente, L. K. Ursell, L. W. Parfrey, R. Knight, The impact of the gut microbiota on human health: An integrative view. Cell 148, 1258–1270 (2012).
5. E. Y. Hsiao, S. W. McBride, S. Hsien, G. Sharon, E. R. Hyde, T. McCue, J. A. Codelli, J. Chow, S. E. Reisman, J. F. Petrosino, P. H. Patterson, S. K. Mazmanian, Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155, 1451–1463 (2013).
6. G. B. Choi, Y. S. Yim, H. Wong, S. Kim, H. Kim, S. V. Kim, C. A. Hoeffer, D. R. Littman, J. R. Huh, The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science 351, 933–939 (2016).
7. L. V. Hooper, A. J. Macpherson, Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 10, 159–169 (2010).
8. J. L. Round, S. K. Mazmanian, The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 9, 313–323 (2009).
9. S. K. Mazmanian, J. L. Round, D. L. Kasper, A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620–625 (2008).
10. K. Honda, D. R. Littman, The microbiome in infectious disease and inflammation. Annu. Rev. Immunol. 30, 759–795 (2012).
11. K. M. Keeney, S. Yurist-Doutsch, M.-C. Arrieta, B. B. Finlay, Effects of antibiotics on human microbiota and subsequent disease. Annu. Rev. Microbiol. 68, 217–235 (2014).
12. C. G. Buffie, V. Bucci, R. R. Stein, P. T. McKenney, L. Ling, A. Gobourne, D. No, H. Liu, M. Kinnebrew, A. Viale, E. Littmann, M. R. M. van den Brink, R. R. Jenq, Y. Taur, C. Sander, J. R. Cross, N. C. Toussaint, J. B. Xavier, E. G. Pamer, Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517, 205–208 (2015).
13. reg cell homeostasis. Science 341, 569–573 (2013).
14. reg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232–236 (2013).
15. S. Fukuda, H. Toh, K. Hase, K. Oshima, Y. Nakanishi, K. Yoshimura, T. Tobe, J. M. Clarke, D. L. Topping, T. Suzuki, T. D. Taylor, K. Itoh, J. Kikuchi, H. Morita, M. Hattori, H. Ohno, Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469, 543–547 (2011).
16. F. Lebreton, R. J. L. Willems, M. S. Gilmore, in Enterococci: From Commensals to Leading Causes of Drug Resistant Infection, M. S. Gilmore, D. B. Clewell, Y. Ike, N. Shankar, Eds. (Massachusetts Eye and Ear Infirmary, 2014).
17. C. M. A. P. Franz, M. Huch, H. Abriouel, W. Holzapfel, A. Gálvez, Enterococci as probiotics and their implications in food safety. Int. J. Food Microbiol. 151, 125–140 (2011).
18. B. Lund, C. Edlund, Probiotic Enterococcus faecium strain is a possible recipient of the vanA gene cluster. Clin. Infect. Dis. 32, 1384–1385 (2001).
19. M. Barthel, S. Hapfelmeier, L. Quintanilla-Martínez, M. Kremer, M. Rohde, M. Hogardt, K. Pfeffer, H. Rüssmann, W.-D. Hardt, Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71, 2839–2858 (2003).
20. E. C. Boyle, N. F. Brown, B. B. Finlay, Salmonella enterica serovar Typhimurium effectors SopB, SopE, SopE2 and SipA disrupt tight junction structure and function. Cell. Microbiol. 8, 1946–1957 (2006).
21. M. Lara-Tejero, J. E. Galán, Salmonella enterica serovar typhimurium pathogenicity island 1-encoded type III secretion system translocases mediate intimate attachment to nonphagocytic cells. Infect. Immun. 77, 2635–2642 (2009).
22. S. Mukherjee, L. V. Hooper, Antimicrobial defense of the intestine. Immunity 42, 28–39 (2015).
23. G. C. Hansson, Role of mucus layers in gut infection and inflammation. Curr. Opin. Microbiol. 15, 57–62 (2012).
24. K. Brandl, G. Plitas, C. N. Mihu, C. Ubeda, T. Jia, M. Fleisher, B. Schnabl, R. P. DeMatteo, E. G. Pamer, Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455, 804–807 (2008).
25. M. Wlodarska, B. Willing, K. M. Keeney, A. Menendez, K. S. Bergstrom, N. Gill, S. L. Russell, B. A. Vallance, B. B. Finlay, Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect. Immun. 79, 1536–1545 (2011).
26. N. Renier, Z. Wu, D. J. Simon, J. Yang, P. Ariel, M. Tessier-Lavigne, iDISCO: A simple, rapid method to immunolabel large tissue samples for volume imaging. Cell 159, 896–910 (2014).
27. I. Gabanyi, P. A. Muller, L. Feighery, T. Y. Oliveira, F. A. Costa-Pinto, D. Mucida, Neuro-immune interactions drive tissue programming in intestinal macrophages. Cell 164, 378–391 (2016).
28. L. M. P. Loonen, E. H. Stolte, M. T. J. Jaklofsky, M. Meijerink, J. Dekker, P. van Baarlen, J. M. Wells, REG3g-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum. Mucosal Immunol. 7, 939–947 (2014).
29. S. Vaishnava, M. Yamamoto, K. M. Severson, K. A. Ruhn, X. Yu, O. Koren, R. Ley, E. K. Wakeland, L. V. Hooper, The antibacterial lectin RegIIIg promotes the spatial segregation of microbiota and host in the intestine. Science 334, 255–258 (2011).
30. C. Stelter, R. Käppeli, C. König, A. Krah, W.-D. Hardt, B. Stecher, D. Bumann, Salmonella-induced mucosal lectin RegIIIb kills competing gut microbiota. PLOS One 6, e20749 (2011).
31. K. G. Watson, D. W. Holden, Dynamics of growth and dissemination of Salmonella in vivo. Cell. Microbiol. 12, 1389–1397 (2010).
32. R. Kansal, D. A. Rasko, J. W. Sahl, G. P. Munson, K. Roy, Q. Luo, A. Sheikh, K. J. Kuhne, J. M. Fleckenstein, Transcriptional modulation of enterotoxigenic Escherichia coli virulence genes in response to epithelial cell interactions. Infect. Immun. 81, 259–270 (2013).
33. A. K. Dey, A. Bhagat, R. Chowdhury, Host cell contact induces expression of virulence factors and VieA, a cyclic di-GMP phosphodiesterase, in Vibrio cholerae. J. Bacteriol. 195, 2004–2010 (2013).
34. C. C. Ginocchio, S. B. Olmsted, C. L. Wells, J. E. Galán, Contact with epithelial cells induces the formation of surface appendages on Salmonella typhimurium. Cell 76, 717–724 (1994).
35. E. I. Armentrout, A. Rietsch, The type III secretion translocation pore senses host cell contact. PLOS Pathog. 12, e1005530 (2016).
36. M. T. Abreu, Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 10, 131–144 (2010).
37. G. Bhinder, M. Stahl, H. P. Sham, S. M. Crowley, V. Morampudi, U. Dalwadi, C. Ma, K. Jacobson, B. A. Vallance, Intestinal epithelium-specific MyD88 signaling impacts host susceptibility to infectious colitis by promoting protective goblet cell and antimicrobial responses. Infect. Immun. 82, 3753–3763 (2014).
38. R. Dessein, M. Gironella, C. Vignal, L. Peyrin-Biroulet, H. Sokol, T. Secher, S. Lacas-Gervais, J.-J. Gratadoux, F. Lafont, J.-C. Dagorn, B. Ryffel, S. Akira, P. Langella, G. Nùñez, J.-C. Sirard, J. Iovanna, M. Simonet, M. Chamaillard, Toll-like receptor 2 is critical for induction of Reg3b expression and intestinal clearance of Yersinia pseudotuberculosis. Gut 58, 771–776 (2009).
39. Y. Valdez, R. B. R. Ferreira, B. B. Finlay, Molecular mechanisms of Salmonella virulence and host resistance. Curr. Top. Microbiol. Immunol. 337, 93–127 (2009).
40. K. S. Kobayashi, M. Chamaillard, Y. Ogura, O. Henegariu, N. Inohara, G. Nuñez, R. A. Flavell, Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731–734 (2005).
41. D. Ramanan, M. S. Tang, R. Bowcutt, P. Loke, K. Cadwell, Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus. Immunity 41, 311–324 (2014).
42. J. M. M. Natividad, V. Petit, X. Huang, G. de Palma, J. Jury, Y. Sanz, D. Philpott, C. L. Garcia Rodenas, K. D. McCoy, E. F. Verdu, Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1−/−; Nod2−/− mice. Inflamm. Bowel Dis. 18, 1434–1446 (2012).
43. K. J. Rangan, V. A. Pedicord, Y.-C. Wang, B.-C. Kim, Y. Lu, S. Shaham, D. Mucida, H. C. Hang, A secreted bacterial peptidoglycan hydrolase enhances tolerance to enteric pathogens. Science 353, 1434–1437 (2016).
44. F. Teng, M. Kawalec, G. M. Weinstock, W. Hryniewicz, B. E. Murray, An Enterococcus faecium secreted antigen, SagA, exhibits broad-spectrum binding to extracellular matrix proteins and appears essential for E. faecium growth. Infect. Immun. 71, 5033–5041 (2003).
45. J. A. Mohamed, F. Teng, S. R. Nallapareddy, B. E. Murray, Pleiotrophic effects of 2 Enterococcus faecalis sagA–like genes, salA and salB, which encode proteins that are antigenic during human infection, on biofilm formation and binding to collagen type I and fibronectin. J. Infect. Dis. 193, 231–240 (2006).
46. K. L. Palmer, K. Carniol, J. M. Manson, D. Heiman, T. Shea, S. Young, Q. Zeng, D. Gevers, M. Feldgarden, B. Birren, M. S. Gilmore, High-quality draft genome sequences of 28 Enterococcus sp. isolates. J. Bacteriol. 192, 2469–2470 (2010).
47. E. P. Culligan, C. Hill, R. D. Sleator, Probiotics and gastrointestinal disease: Successes, problems and future prospects. Gut Pathog. 1, 19 (2009).
48. L. M. Dicks, M. Botes, Probiotic lactic acid bacteria in the gastro-intestinal tract: Health benefits, safety and mode of action. Benef. Microbes 1, 11–29 (2010).
49. D. A. Leffler, J. T. Lamont, Clostridium difficile infection. N. Engl. J. Med. 373, 287–288 (2015).
50. B. Lemaitre, I. Miguel-Aliaga, The digestive tract of Drosophila melanogaster. Annu. Rev. Genet. 47, 377–404 (2013).
51. S. Rakoff-Nahoum, R. Medzhitov, Role of the innate immune system and host–commensal mutualism. Curr. Top. Microbiol. Immunol. 308, 1–18 (2006).
52. T. Miki, O. Holst, W.-D. Hardt, The bactericidal activity of the C-type lectin RegIIIb against Gram-negative bacteria involves binding to lipid A. J. Biol. Chem. 287, 34844–34855 (2012).
53. R. E. Lehotzky, C. L. Partch, S. Mukherjee, H. L. Cash, W. E. Goldman, K. H. Gardner, L. V. Hooper, Molecular basis for peptidoglycan recognition by a bactericidal lectin. Proc. Natl. Acad. Sci. U.S.A. 107, 7722–7727 (2010).
54. T. Miki, W.-D. Hardt, Outer membrane permeabilization is an essential step in the killing of gram-negative bacteria by the lectin RegIIIb. PLOS One 8, e69901 (2013).
55. A. Olson, L. N. Diebel, D. M. Liberati, Effect of host defenses on Clostridium difficile toxin–induced intestinal barrier injury. J. Trauma Acute Care Surg. 74, 983–990 (2013).
56. X. Sun, S. A. Hirota, The roles of host and pathogen factors and the innate immune response in the pathogenesis of Clostridium difficile infection. Mol. Immunol. 63, 193–202 (2015).
57. H. Y. Lee, S. Crawley, R. Hokari, S. Kwon, Y. S. Kim, Bile acid regulates MUC2 transcription in colon cancer cells via positive EGFR/PKC/Ras/ERK/CREB, PI3K/Akt/IkB/NF-kB and p38/MSK1/CREB pathways and negative JNK/c-Jun/AP-1 pathway. Int. J. Oncol. 36, 941–953 (2010).
58. M. E. V. Johansson, J. M. H. Larsson, G. C. Hansson, The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc. Natl. Acad. Sci. U.S.A. 108 (suppl. 1), 4659–4665 (2011).
59. A. Brune, C. Dietrich, The gut microbiota of termites: Digesting the diversity in the light of ecology and evolution. Annu. Rev. Microbiol. 69, 145–166 (2015).
60. A. C. Silver, N. M. Rabinowitz, S. Küffer, J. Graf, Identification of Aeromonas veronii genes required for colonization of the medicinal leech, Hirudo verbana. J. Bacteriol. 189, 6763–6772 (2007).
61. S. M. Lee, G. P. Donaldson, Z. Mikulski, S. Boyajian, K. Ley, S. K. Mazmanian, Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 501, 426–429 (2013).
62. N. Kamada, Y.-G. Kim, H. P. Sham, B. A. Vallance, J. L. Puente, E. C. Martens, G. Núñez, Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 336, 1325–1329 (2012).
63. M. Candela, F. Perna, P. Carnevali, B. Vitali, R. Ciati, P. Gionchetti, F. Rizzello, M. Campieri, P. Brigidi, Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: Adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int. J. Food Microbiol. 125, 286–292 (2008).
64. C. G. Buffie, E. G. Pamer, Microbiota-mediated colonization resistance against intestinal pathogens. Nat. Rev. Immunol. 13, 790–801 (2013).
65. F. C. Lessa, Y. Mu, W. M. Bamberg, Z. G. Beldavs, G. K. Dumyati, J. R. Dunn, M. M. Farley, S. M. Holzbauer, J. I. Meek, E. C. Phipps, L. E. Wilson, L. G. Winston, J. A. Cohen, B. M. Limbago, S. K. Fridkin, D. N. Gerding, L. C. McDonald, Burden of Clostridium difficile infection in the United States. N. Engl. J. Med. 372, 825–834 (2015).
66. Y. Vincent, A. Manji, K. Gregory-Miller, C. Lee, A review of management of Clostridium difficile infection: Primary and recurrence. Antibiotics 4, 411–423 (2015).
67. S. J. Allen, K. Wareham, D. Wang, C. Bradley, H. Hutchings, W. Harris, A. Dhar, H. Brown, A. Foden, M. B. Gravenor, D. Mack, Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): A randomised, double-blind, placebo-controlled, multicentre trial. Lancet 382, 1249–1257 (2013).
68. J. A. Sorg, S. S. Dineen, Laboratory maintenance of Clostridium difficile. Curr. Protoc. Microbiol. Chapter 9, Unit9A.1 (2009).
69. N. H. Salzman, H. de Jong, Y. Paterson, H. J. M. Harmsen, G. W. Welling, N. A. Bos, Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology 148, 3651–3660 (2002).
70. A. Swidsinski, J. Weber, V. Loening-Baucke, L. P. Hale, H. Lochs, Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J. Clin. Microbiol. 43, 3380–3389 (2005).
71. S. Kang, S. E. Denman, M. Morrison, Z. Yu, C. S. McSweeney, An efficient RNA extraction method for estimating gut microbial diversity by polymerase chain reaction. Curr. Microbiol. 58, 464–471 (2009).
72. G. Zhang, E. W. Brown, N. González-Escalona, Comparison of real-time PCR, reverse transcriptase real-time PCR, loop-mediated isothermal amplification, and the FDA conventional microbiological method for the detection of Salmonella spp. in produce. Appl. Environ. Microbiol. 77, 6495–6501 (2011).
73. J. Abernathy, C. Corkill, C. Hinojosa, X. Li, H. Zhou, Deletions in the pyruvate pathway of Salmonella Typhimurium alter SPI1-mediated gene expression and infectivity. J. Anim. Sci. Biotechnol. 4, 5 (2013).